126 related articles for article (PubMed ID: 6929726)
1. Amygdalin (Laetrile): effect on clonogenic cells from human myeloid leukemia cell lines and normal human marrow.
Koeffler HP; Lowe L; Golde DW
Cancer Treat Rep; 1980 Jan; 64(1):105-9. PubMed ID: 6929726
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of differentiation and proliferation of colony-stimulating factor-induced clonal growth of normal human marrow cells in vitro by retinoic acid.
Bradley EC; Ruscetti FW; Steinberg H; Paradise C; Blaine K
J Natl Cancer Inst; 1983 Dec; 71(6):1189-92. PubMed ID: 6606727
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
De Fabritiis P; Pulsoni A; Sandrelli A; Simone F; Amadori S; Meloni G; Mandelli F
Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
[TBL] [Abstract][Full Text] [Related]
4. Human bone marrow fibroblastic cells can inhibit clonogenic growth of K562 cells.
Noguchi K; Nagao T; Arimori S
Tokai J Exp Clin Med; 1985 Oct; 10(5):537-43. PubMed ID: 3870061
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
[TBL] [Abstract][Full Text] [Related]
6. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
Gidáli J; Fehér I; Kovács P
Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells.
Bendall LJ; Daniel A; Kortlepel K; Gottlieb DJ
Exp Hematol; 1994 Dec; 22(13):1252-60. PubMed ID: 7957711
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow.
Atzpodien J; Gulati SC; Clarkson BD
Cancer Res; 1986 Oct; 46(10):4892-5. PubMed ID: 3756850
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition by thymidine of leukemic HL-60 and normal human myeloid progenitor cells.
Akman SA; Ross DD; Rosen H; Salinger C; Andrews PA; Chou FE; Bachur NR
Cancer Res; 1981 Jun; 41(6):2141-6. PubMed ID: 6940654
[TBL] [Abstract][Full Text] [Related]
10. Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1.
Pelus LM; Broxmeyer HE; Clarkson BD; Moore MA
Cancer Res; 1980 Jul; 40(7):2512-5. PubMed ID: 6930324
[TBL] [Abstract][Full Text] [Related]
11. Selective photosensitization of human leukemic cells by a pyrene-containing fatty acid.
Fibach E; Gatt S; Rachmilewitz EA
Exp Hematol; 1990 Feb; 18(2):89-93. PubMed ID: 2303106
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapeutic susceptibility of human bone marrow progenitor cells and human myelogenous leukemia cells (HL-60) in co-culture: preliminary report.
Himori T; Ohnuma T; Holland JF
Int J Cell Cloning; 1984 Jul; 2(4):254-62. PubMed ID: 6589302
[TBL] [Abstract][Full Text] [Related]
13. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
14. Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1.
Okuda K; Matulonis U; Salgia R; Kanakura Y; Druker B; Griffin JD
Exp Hematol; 1994 Oct; 22(11):1111-7. PubMed ID: 7925778
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia.
Takahashi S; Okamoto SI; Shirafuji N; Ikebuchi K; Tani K; Shimane M; Matsudaira T; Irie S; Tsuruta T; Matsuishi E
Bone Marrow Transplant; 1994 Mar; 13(3):239-45. PubMed ID: 7515298
[TBL] [Abstract][Full Text] [Related]
16. Elimination of leukemic cells by the combined use of ether lipids in vitro.
Okamoto S; Olson AC; Vogler WR
Cancer Res; 1987 May; 47(10):2599-603. PubMed ID: 3471316
[TBL] [Abstract][Full Text] [Related]
17. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
19. Limiting dilution analysis of a novel tripeptide anticancer agent Ambamustine (PTT-119): effect on K-562, CCRF-SB and multidrug resistant LoVo-Dk cell lines.
Manna A; Porcellini A; Visani G; Marchetti-Rossi MT; Tura S
Exp Hematol; 1994 Jun; 22(6):517-20. PubMed ID: 8187848
[TBL] [Abstract][Full Text] [Related]
20. Behavior in vitro of long-term cultured bone marrow or blood cells from chronic myeloid leukemia: adhesion molecules and differentiation antigens as detected by immunocytochemistry.
Pasternak G; Pasternak L
Folia Biol (Praha); 1994; 40(6):439-54. PubMed ID: 7589702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]